Although these results were not consistent with a previous report which demonstrated that the administration of androgens resulted in increased AR mRNA levels in LNCaP cells(21), our data are strongly supported by the analysis of clinical prostate cancer specimens(22,23). This evidence concerns the gene AR and prostate cancer.